Literature DB >> 14541215

Development of recombinant Streptomyces for biotechnological and environmental uses.

D L Crawford1.   

Abstract

Recombinant DNA techniques for manipulation of genes in Streptomyces are well developed, and currently there is a high level of activity among researchers interested in applying molecular cloning and protoplast fusion techniques to strain development within this commercially important group of bacteria. A number of efficient plasmid and phage vector systems are being used for the molecular cloning of genes, primarily those encoding antibiotic biosynthesis enzymes, but also for a variety of other bioactive proteins and enzymes of known or potential commercial value. In addition, cloning aimed at constructing specialized bioconversion strains for use in the production of chemicals from organic carbon substrates is underway in numerous laboratories. This review discusses the current status of research involving recombinant DNA technologies applied to biotechnological applications using Streptomyces. The topic of potential environmental uses of recombinant Streptomyces is also reviewed, as is the status of current research aimed at assessing the fate and effects of recombinant Streptomyces in the environment. Also summarized is recent research that has confirmed that genetic exchange occurs readily among Streptomyces in the soil environment and which has shown the potential for exchange between recombinant Streptomyces and native soil bacteria.

Entities:  

Year:  1988        PMID: 14541215     DOI: 10.1016/0734-9750(88)90004-3

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  2 in total

1.  Improved production of heterologous protein from Streptomyces lividans.

Authors:  G F Payne; N DelaCruz; S J Coppella
Journal:  Appl Microbiol Biotechnol       Date:  1990-07       Impact factor: 4.813

Review 2.  An insight into the "-omics" based engineering of streptomycetes for secondary metabolite overproduction.

Authors:  Amit Kumar Chaudhary; Dipesh Dhakal; Jae Kyung Sohng
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.